|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00876 KAISA HEALTH
Nominal 
0.023 0.000 (0.000%) | 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Turnover | 69,577 | -21.396% | 185,357 | 185,882 | 191,499 | 209,626 |
| Cost of Sales | (44,383) | -12.397% | (103,499) | (104,809) | (108,934) | (112,211) |
| Gross Profit | 25,194 | -33.441% | 81,858 | 81,073 | 82,565 | 97,415 |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | (64,129) | -- | |
| Change in FV & Impairment on Others | 8,979 | -- | (29,838) | (25,310) | (41,237) | 57,950 | |
| Profit / (Loss) on Disposal | -- | -- | -- | 69,391 | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (9,334) | -58.736% | (48,681) | 6,046 | (170,963) | 11,203 | |
| Taxation | 49 | -- | (1,919) | 104 | (1,169) | (23,526) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 160 | -- | 4,245 | 1,318 | 48,814 | 14,682 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (9,125) | -62.393% | (46,355) | 7,468 | (123,318) | 2,359 | |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Net Finance Costs / (Income) | (518) | -23.935% | (536) | 594 | 4,725 | 6,864 |
| Depreciation & Amortisation | 6,409 | -16.993% | 15,174 | 17,887 | 31,312 | 27,390 |
| Directors' Emoluments | -- | -- | 17,771 | 18,105 | 23,123 | 20,446 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -0.180 | -62.500% | -0.920 | 0.150 | -2.450 | 0.050 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.007) | (0.007) | (0.012) | (0.024) |
| NBV per share ($) | 0.086 | -- | 0.086 | 0.098 | 0.096 | 0.129 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -9,125 |
| %Change | -62.393% |
| EPS / (LPS) | HKD -0.002 |
| NBV Per Share ($) | HKD 0.086 |